chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever to 102.8, myalgias, dizziness, headache, weakness, nausea, vomiting x 4.
Headache; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and MYALGIA (Body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced HEADACHE (Headache) and MYALGIA (Body ache). At the time of the report, HEADACHE (Headache) and MYALGIA (Body ache) had not resolved. Not Provided          Reporter did not allow further contact
Information has been received from a 47 year old male consumer with allergy to water pills who in May 2008, was vaccinated in the left arm with first dose of PNEUMOVAX (dose, route and lot number not reported).  There was no concomitant medication.  The consumer reported that he was hospitalized prior to receive the vaccine due to a coma from "pneumonia in the pancreas" and seizures.  Before he was discharged from the hospital he was given a dose of PNEUMOVAX.  He believed that it was a "bad shot" because it was "milky white".  He had an immediate reaction with arm numbness beginning one to two minutes after vaccination.  He said his whole arm swelled for four months.  The consumer reported that "he now has numbness from his arm to his ribcage".  The patient's numbness from his arm to ribcage persisted.  The patient was seen by two neurologists.  Additional information is not expected.
Started with numbness - shoulder - upper arm - hand of left. Progressively became worse during day and lost grip. Could not push door open. Difficult to raise arm. 1st clinic ran tests then said to see neurologist - ER Neurologist3PM spinal and cat scan - assumed it was flu shot - she will follow up with neurologist week of 11/19/13. Slow improvement.
I think I am having a bad reaction to it; the first dose I was a little light headed and I had like headache; I think I am having a bad reaction to it; the first dose I was a little light headed and I had like headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 05May2021 (Lot number: EW0167) at the age of 47 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing); "Allergies/Outdoor allergies" (unspecified if ongoing). Concomitant medication(s) included: ZYRTEC [CETIRIZINE HYDROCHLORIDE] taken for hypersensitivity. The following information was reported: DIZZINESS (non-serious), HEADACHE (non-serious) all with onset 2021, outcome "unknown" and all described as "I think I am having a bad reaction to it; the first dose I was a little light headed and I had like headache".  Additional information: It was reported that, patient was just calling because she had the second shot of the Pfizer (Pfizer Covid Vaccine) and she think she was having a bad reaction to it. The first dose she was a little light headed and she had like headache and then the second dose, she had her head was hurting on yesterday and then she woke up this morning her whole body was aching and fever and chills and my head hurts real bad."   No follow-up attempts are possible. No further information is expected.
12/18/2020 02:45 AM WOKE UP BECAUSE UPPER RIGHT SIDE OF BACK, WAS HURTING, THROBBING, WOKE ME UP. STOOD UP, KEPT HURTING AND GETTING MORE INTENSE.  BROKE OUT IN SWEAT, UNCOMFORTABLE, PAIN, DRY HEAVES DUE TO INTENSITY OF PAIN; 10/10 PAIN LEVEL 'SOLID'; LASTED 45 MINUTES. FELL BACK ASLEEP, WENT TO WORK 12/18/2020 THAT DAY. FELT LIKE IT WAS BRUISED 'KIDNEY AREA' ON UPPER R BACK. I BELIEVE IT WAS EVENING, I URINATE AND FELT 'SLIGHT BURNING' SENSATION; THIS HAPPENED THE REST OF THE EVENING.  12/19/2020 WENT TO CLINIC. DR. STATED URINED SAMPLE WAS NEGATIVE; UNDISCLOSED DIAGNOSIS OF URTHRITIS. GIVEN SHOT OF ANTIBIOTIC, AND PRESCRIBED ANTIBIOTIC FOR 7 DAYS.  12/20/2020-12/23/2020 FELT FATIGUED AND MALAISE. FELT LIKE JOINTS WERE 'TIRED' AND 'ACHY'; 'SLIGHTLY OFF'.  2 HOURS AFTER VACCINATION ON 12/18/2020 - 'TICKLE IN MY THROAT', STAYED AND IRRITATED, BROUGHT ON COUGHING. STAYED UNTIL 12/19/2020 WHICH TURNED INTO A RASPY WITH EXCESSIVE THROAT CLEARING. I DO DRINK A LOT OF WATER, STAYING HYDRATED.  FLU VACCINE IN POSSIBLY OCT 2020
Severe abdominal pain upper left  side  Shortness of breath  Chest pain Severe fatigue  Numbness in arms at night
uncontrollable cough and emesis,  migraine, undescribable body pain to my bones, freezing and sweating, and crying. I thought I was dying. It started at midnight and was still continuing at 1000 am so I was taken to the ER.  The ER gave me zofran and tylenol.  The migraine and body pain cont until Tuesday, had nausea then also until Tuesday. No energy until today. I went from 104 lbs to 100 lbs. I am still coughing and cough syrup is not helping.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 18-DEC-2014, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 12-JUL-2016, the patient was treated by a physician for a vesicular outbreak, accompanied by weakened immune symptoms, which was diagnosed as herpes zoster. The patient has been prescribed VALTREX, 'methyl-prednisone', and gabapentin for management of her painful symptoms and excruciating pain. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome is unknown. Additional information has been requested.
A pharmacist reported that his infant son received his first dose of Prevnar on an unspecified date at approximately 2 months of age. Around the same time, the infant developed mild rectal bleeding. He was diagnosed with a milk protein allergy and paced on special formula. Subsequently, the rectal bleeding resolved, and it was attributed to the milk protein allergy. No further information was available at the date of this report. The infant developed rectal bleeding following receipt of his second dose of Prevnar along with DTP (manufacturer unknown) and Motrin (ibuprofen) at approximately 4 months of age and his third dose of Prevnar along with DTP (manufacturer unknown) at approximatel 6 months of age (see MCN HQWYE492006JUN03 and MCN HQWYE492106JUN03)
Itching, redness, Swelling, warmth, discomfort in left arm that started 7 days after vaccine was given. Much better now but still with smaller area of sight redness and slight itching
double vision; blurry vision; This case was reported by a consumer via call center representative and described the occurrence of double vision in a 75-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had a first outbreak of Shingles 1st July 2021 on his left side affecting his eyes and eyebrows). Concurrent medical conditions included diabetes. Concomitant products included famciclovir.   On 11th July 2021, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In July 2021, less than a week after receiving Shingrix, the patient experienced double vision and blurred vision. On an unknown date, the outcome of the double vision and blurred vision were not recovered/not resolved.   It was unknown if the reporter considered the double vision and blurred vision to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient himself. The patient went to his patient care physician (PCP) and was prescribed famciclovir 500 mg bid.  On 11th July 2021, patient went back to his primary care physician office and his famciclovir order was extended and he received the first dose of Shingrix.  Three to four days later he had blurry vision and double vision, both were unresolved.  The patient went to an eye doctor that said his vision should clear up in 4 to 5 months and to cover one eye while driving. The reporter consented to follow up.
Within 3 hours eyes swelled shut, coughing, sore throat, fever, face and chest red.
I have had heart palpations, lethargic, headaches constantly,dizziness, constant no energy- bedridden,muscle soreness, balance issues, brain fog, and major fatigue. Still to this day, 2 yrs later.
Deltoid of right arm is red and swollen. Area appears to have scabbed over and scab is now gone leaving area exposed. Patient says that there has been pus in area. Pharmacy called Dr. about patient's arm and Dr. prescribed KEFLEX. Patient has now finished dose of KEFLEX and area is not any better.
Developed apparent cellulitis over (L) upper arm injection site. Treated with Z-PACK & Prednisone tabs.
Pt said arm got red and itchy after not long after injection.  Got a little worse over next 2 days. Area is red and dry and itchy. Said it is tender to touch.
Pt had mild fever, swelling and warmth at injection site, headache and pain at injection site, all of which lasted approx. 3 days.
This spontaneous report as received from a certificate medical assistant refers to a unspecified number of patients of unknown age and gender. The patients medical history and current conditions were not provided. On an unknown date, the patients were vaccinated with a doses of incorrectly storage PROQUAD (Merck) (doses and routes were not reported) lot # K012919 expiration date 28-FEB-2016 and lot # reported as K013867 expiration date 05-MAR-2016. Secondary suspects and concomitant therapies were not reported. No adverse effects reported by any patient. Additional information has been requested. This is one of several reports received from the same reporter.
vaccinated and I got shingles/suspected vaccination failure; shingles; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got vaccinated with Shingles vaccine and got shingles anyway. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Arm is red; Arm is swollen; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm is red) and SWELLING (Arm is swollen) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced ERYTHEMA (Arm is red) and SWELLING (Arm is swollen). At the time of the report, ERYTHEMA (Arm is red) and SWELLING (Arm is swollen) had not resolved.            No concomitant medications provided.  Action taken with mRNA-1273 in response to the event was not applicable.
High respiratory rate with shallow breaths, Rash on chest, Tachycardia, Altered Mental Status .  The Patient that was suspected to have an adverse reaction.  EKG displayed no abnormalities,  IV was placed in patients L Arm and provided 1,000 ML of Normal Saline, and administered supplemental O2 via simple mask.  An Epinephrine Auto Injector 0.3mg was also injected into the patients L thigh.  Determination to transport to local treatment center was made by provider.  Patient arrived at Medical Center approx. at 2245 and further evaluated there.  Patient was then transferred to Level 3 Trauma facility to Hospital around 0100, 17 March.   Admitted to the ICU for further evaluation.  Update- Patient will be admitted until 18 Mar 2021.  It was noted by Hospital Patient had a sever anaphylactic reaction.
Pt complains of lethargy and nausea x 2days, soreness in arm and received ZOFRAN and Ibuprofen from MD on day 3.
MMR/Varicella (PROQUAD), PREVNAR, HIB, HEP A given 2/4/14 at 1:53 PM. Patient had fever 103, emesis and irritability. No weight bearing that day. Was sent to ER. Given ZOFRAN and MOTRIN. Symptoms continued. Fever 103-104 into 206/14. Fluids advised and alternate Ibup and Acetaminophen.
rash on face , loss of taste , and voice , tightness in throat  started at 245  .
high fever, 102.1  in evening of short date received, took Tylenol.   Tongue and lips tingling and loss of taste on Tuesday morning and fever of 101.9 took Tylenol  Wednesday March 31, tongue and lips still continue to tingle and loss of taste.  Thursday still running fever 99.9.  Friday Morning fever gone however tongue and lips still tingle and loss of taste still present.
Both arms, above elbows red, swollen, joints ache, red streak inside right arm by elbow. Upper arms warm to touch.
Rash/hives- started 6 days from vaccine.  Started in right arm.  Took allergy medication and hydrocortisone cream to treat- would clear up.  Hives would come back as meds wore off- different areas at different times over the last 3 days.  Once I had hives covering me from the neck down to my feet.   Took more meds and would go away.
no additional AE'S; mproperly Stored; Administered; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/ allergies were not reported.  On 06-APR-2021, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # 1687290, expiration date was reported as 02-SEP-2022, but upon internal validation established as 06-SEP-2022; dose and route were not reported) for prophylaxis, the vaccine was temperature excursion (product storage error). No additional AE reported.   The administered dose of the vaccine experienced a temperature excursion of 28.34 Fahrenheit (F) for 1 hour and 2 minutes. There was previous temperature excursion (30.28F for 19 minutes; 34.81F for 35 minutes). The digital data logger was involved. Device of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not available for evaluation (obtain was false).  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1687290; expirationdate: 06-SEP-2022; deviceage and unit: 0 ; malfunction: Unknown; productavailableforevaluation: No; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2104USA002505: US-009507513-2104USA002840: US-009507513-2104USA002841: US-009507513-2104USA002847: US-009507513-2104USA002848: US-009507513-2104USA002849: US-009507513-2104USA002850:
Reported feeling achy / feverish late evening after vaccines.  Took IBUPROFEN around 1-7:30am approximately 12 hrs after vaccination.  At 1:30am had seizure transported to emergency room diagnosed with febrile seizure.  After fever resolved reports feeling normal.  Was released from ER 10/26/08
During post vaccination observation period reported feeling hot and nauseous. Was hypertensive 214/102 and couldn't recall if she took her antihypertension medicine that day. BP decreased to 187/86, pt anxious and felt tingling sensation and tightness in face and gums. Transported to ED, no difficulty breathing, no facial swelling and no hives. Given diphenhydramine and d/c to home.
This spontaneous report as received from other refers to a female patient of unknown age (patient's age: 22 (units not specified)). The patient's medical history, concurrent condition and concomitant medications were not reported. On an unknown date the patient was vaccinated with RECOMBIVAX HB from lot # M043422 expiry date 31-JUL-2017 on her right arm. On 18-JUL-2017, the patient stated that she could not move her right arm after the injection. The patient was currently being treated with booster shots. The patient does not have any known allergies and this was the first time being given this. The outcome of hypoaesthesia was unknown. Causality assessment was not provided.
This spontaneous report as received from a certified medical assistant (C.M.A.) refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 19-NOV-2015, the patient was vaccinated with an improperly stored dose of GARDASIL 9 lot # L017407, expiration date: 15-AUG-2015 or lot # L016428, expiration date: 30-JUl-2017 (it was not specified by the reporter which lot was administered) (dose, route of administration and location were not reported). No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  OBSTRUCTIVE SLEEP APNEA  7/13/2022  --  RECURRENCE OF SAME SYMPTOMS
AFIB episodes; heart palpitations; This is a spontaneous report from a contactable consumer (patient). A 47-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EW0198), via an unspecified route of administration, administered in arm right on 12Jul2021 at 10:15 (at the age of 47-years-old) as dose 1, single for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, asthma, COVID-19 and AFIB (atrial fibrillation) from an unknown date; and heart ablation from 22Jun2020 (I had a heart Ablation due to AFIB on 22Jun) to an unknown date. The patient 9 AFIB episodes and heart palpitations on 12Jul2021 at 11:15. The clinical course was as follows: The patient had a heart ablation due to AFIB on 22Jun. Approximately 1 hour after receiving her 1st dose, she begun having the same level of heart palpitations as i did prior to her surgery. She had to take additional doses of Flacenide that she uses to regulate her heart. She has had at least 9 AFIB episodes daily since then when they had all but stopped after her surgery. Therapeutic measures were taken as a result of both events. The outcome of the events was recovered with sequelae on an unspecified date.    No follow-up attempts are needed. No further information is expected.
Patient reports over phone on 09/20/23 that it was given by pharmacist in area between the armpit and elbow of patient's arm. There is bruising and redness that has grown overtime since shot on 09/12/23. Patient has not report going to seek a PCP or ER or Urgent care.
Patient received GARDASIL, VARIVAX and Hepatitis A vaccines during her pregnancy. She did not know she was pregnant at the time of receiving vaccines.
On 04 /28/2022 I went to the hospital to get urine and blood test which was referred by my doctor. The results were given around 10:20AM. They found blood, mucus, and bacteria in my urine.  They even did urine culture it was negative. They did it again after couple of weeks later it was negative again.  My doctor referred me to a Urologist. I went to the Urologist yesterday on 11/01/2022 and they did few more tests this time everything was normal even though I still have little blood present in my urine.
light headed; diarrhea; hot around the injection site; hard around the injection site; Fever of 101.5 F; nauseated; headache; very red around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light headed), DIARRHOEA (diarrhea), VACCINATION SITE WARMTH (hot around the injection site), VACCINATION SITE INDURATION (hard around the injection site) and PYREXIA (Fever of 101.5 F) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced DIZZINESS (light headed), DIARRHOEA (diarrhea), VACCINATION SITE WARMTH (hot around the injection site), VACCINATION SITE INDURATION (hard around the injection site), PYREXIA (Fever of 101.5 F), NAUSEA (nauseated), HEADACHE (headache) and VACCINATION SITE ERYTHEMA (very red around the injection site). On 20-Mar-2021, DIZZINESS (light headed), DIARRHOEA (diarrhea), VACCINATION SITE WARMTH (hot around the injection site), VACCINATION SITE INDURATION (hard around the injection site), PYREXIA (Fever of 101.5 F), NAUSEA (nauseated), HEADACHE (headache) and VACCINATION SITE ERYTHEMA (very red around the injection site) had resolved.            Patient takes blood pressure medicines but no further information.  No concomitant medications are reported by the reporter. No treatment information is provided.   This case was linked to MOD-2021-056406, MOD-2021-247019.
Macular rash to chest, abdomen, upper back, and neck Fever, fatigue, body aches
Pt recvd vax & devel panniculitis characterized by a fever & swelling;
Patient came to the pharmacy because she had adverse reaction to ZOSTAVAX vaccine. The symptoms were redness at the injection site, rash that extend the left side of the body and pain that extends from the neck to left arm. She visited emergency room and the treatment was Azithromycin 250 mg and CATAFLAM 50 mg. The day after, she states the rash gone and pain was reduced a lot.
Atypical.... sore arm shortly after injection. Next day, achey muscles, headache, fatigue. Ibuprofen seems to somewhat ease muscle aches. Not bad enough to seek further help.  Just for informational purposes.
severe shingles on the right upper face.  Right eye and right face was swollen. Visited ER room, almost hospitalized. Crack was detected on the cornea. 1) Anti-inflammatory, antiviral and antibiotic medicine were given to the first 10 days at the maximum doses each day. 2) Blisters were crusted after 2 weeks 3) severe nerve pain after the rash was gone.  4) Lyrica was prescribed but didn't show much effect in reducing the pain.
She could move, her ayes were big (scared) she was shaking and drooling, was very heavy...(fever seizure) they said at the hospital. Doctor at ER said that it looked like a reaction to the PC vaccine. HIB serial number: UIT627AB  U9281-545-05 PC PREVNAR wyeth: G131939.